The ITER neutral beam (NB) injectors are the first injectors that will have to operate in a hostile radiation environment and they will become highly radioactive due to the neutron flux from ITER. The injectors will use a single large ion source and accelerator that will produce 40 A 1 MeV Dbeams for pulse lengths of up to 3600 s. Significant changes have been made to the ITER heating NB injector (HNB) over the past 4 years. The main changes are: o Modifications to allow installation and maintenance of the beamline components with an overhead crane. o The RF driven negative ion source developed by IPP Garching has replaced the filamented ion source from JAEA, Naka as the reference design. o The ion source and extractor power supplies will be located in an air insulated high voltage (-1 MV) deck located outside the tokamak building instead of inside an SF 6 insulated HV deck located above the injector. The development of the ITER accelerators and ion sources has been carried out on relatively low powered test stands, making impossible the full demonstration of the ITER requirements. Padua Research on Injectors with Megavolt Acceleration (PRIMA, ex-NBTF) will be built to allow the R&D necessary to finalise the development of the full power system
The JET 2019-2020 scientific and technological programme exploited the results of years of concerted scientific and engineering work, including the ITER-like wall (ILW: Be wall and W divertor) installed in 2010, improved diagnostic capabilities now fully available, a major Neutral Beam Injection (NBI) upgrade providing record power in 2019-2020, and tested the technical & procedural preparation for safe operation with tritium. Research along three complementary axes yielded a wealth of new results. Firstly, the JET plasma programme delivered scenarios suitable for high fusion power and alpha particle physics in the coming D-T campaign (DTE2), with record sustained neutron rates, as well as plasmas for clarifying the impact of isotope mass on plasma core, edge and plasma-wall interactions, and for ITER pre-fusion power operation. The efficacy of the newly installed Shattered Pellet Injector for mitigating disruption forces and runaway electrons was demonstrated. Secondly, research on the consequences of long-term exposure to JET-ILW plasma was completed, with emphasis on wall damage and fuel retention, and with analyses of wall materials and dust particles that will help validate assumptions and codes for design & operation of ITER and DEMO. Thirdly, the nuclear technology programme aiming to deliver maximum technological return from operations in D, T and D-T benefited from the highest D-D neutron yield in years, securing results for validating radiation transport and activation codes, and nuclear data for ITER.
Alpha particles with energies on the order of megaelectronvolts will be the main source of plasma heating in future magnetic confinement fusion reactors. Instead of heating fuel ions, most of the energy of alpha particles is transferred to electrons in the plasma. Furthermore, alpha particles can also excite Alfvénic instabilities, which were previously considered to be detrimental to the performance of the fusion device. Here we report improved thermal ion confinement in the presence of megaelectronvolts ions and strong fast ion-driven Alfvénic instabilities in recent experiments on the Joint European Torus. Detailed transport analysis of these experiments reveals turbulence suppression through a complex multi-scale mechanism that generates large-scale zonal flows. This holds promise for more economical operation of fusion reactors with dominant alpha particle heating and ultimately cheaper fusion electricity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.